Scientists spotted RPS-12 protein as a potential target for anti-cancer therapy

January 29, 2021

Using the developing eye of the fruit fly as a test platform, researchers found that RPS-12 protein overproduction appears to trigger triple-negative breast cancer and possibly some other malignancies. The protein indirectly switches on an important inracellular signaling pathway active while the embryo develops and shut down in healthy cells of adults. Far Eastern Federal University (FEFU), the University of Geneva, and the Institute of Protein Research (Russia) scientists addressed the problem in Scientific Reports.

Researchers have taken another step towards targeted treatment of tumors. The idea of such a therapy is to identify the necessary target proteins playing instructive functions in tumor initiation or progression in order to suppress tumor development while causing minimal harm to healthy cells.

Using fruit flies and a cDNA library of patient-derived triple-negative breast cancer, scientists launched a massive screening for potential novel human oncogenes, i.e. genes that after a mutation activate elements of cancerous transformation. To find the potential targets, scientists inserted genes found in the human tumor into the Drosophila genome, drove their misexpression in the eye of the insect, and observed the potential defects in the development of this sensitive organ.

After they transplanted the human protein RPS-12, the Drosophila eye shrank and obtained a mirror-like appearance.

"This phenomenon reminds the classic glazed phenotype that Thomas Morgan, the father of Drosophila genetics, discovered back in the 1920s. Only in the 90s of the 20th century, it was understood that the mutation affects the Wingless gene. This Drosophila gene corresponds to the WNT genes that trigger the signaling pathway of the same name in humans. The activity of the WNT signaling pathway is vital for the development of the human body at the embryonic stage, though switched off at later stages. Mutations or epigenetic changes can reboot the signaling pathway in adults. After that, the initially healthy cells start a massive proliferation. This is one of the reasons for the development of triple-negative breast cancer and some other forms of cancer, such as in the colon, liver, ovaries, etc.", explains Vladimir Katanaev, the project ideologist, head of the laboratory of pharmacology of natural compounds at the FEFU School of Biomedicine.

Scientists revealed that the phenotype of the glazed eye arises because the expression of human RPS12 in the eye of Drosophila overactivates the WNT / Wingless-signaling pathway. The overabundance of RPS12 protein stimulates the production of active forms of Wingless capable of diffusing over long distances in the tissue and reaching distant cells. Reciprocally, the reduced amount of RPS12 decreases the production of such Wingless forms.

"The proteins of the Wingless-WNT family are very "sticky". Their natural distribution in the body tissues is limited, and the number of active forms migrating over long distances is under strict regulation. WNT is an example of morphogens, i.e. substances that are produced in specific places during embryogenesis and spread through the tissue generating a concentration gradient. If we consider a human hand as an example, the palm, elbow, and shoulder are formed due to the reaction of cells to different concentrations of the WNT morphogen", says Vladimir Katanaev.

Special mechanisms are responsible for the production of WNT-forms capable of spreading through tissue over long distances. One of the mechanisms the team studied earlier is based on the protein reggie-1/fotillin-2.

"It turned out that RPS12 plays a similar role. Thus, we have unveiled a new mechanism for controlling the production of active forms of WNT, and suggest that the RPS12 protein may become a new potential target for anticancer therapy. Further research will show how this protein is really suitable for therapeutic targeting", concluded Vladimir Katanaev.

About 70-80 percent of the genes responsible for human disease have orthologous genes in Drosophila. Evolutionary, these are practically the same genes, but with some individual sequences in humans and fruit flies.

The Drosophila eye development is complex and multistage. At various phases of its development, various signaling pathways and cellular mechanisms one knows in humans become active. Based on this, scientists assumed that any human oncogene, if "transplanted" into the eye of a Drosophila, would lead to a disruption in the development of this organ. A fly with an affected eye lives up to maturity, meaning that it is easy to observe the eye developmental disorders, simply by studying the insect through a microscope.

Scientists started the HumanaFly project more than 10 years ago at the Institute of Protein Research (Pushchino, Russia) in order to find new human oncogenes via the fruit fly eye screening platform. The final experiments of the first phase were carried out in 2020. An extensive genetic library has been formed for the subsequent search for components and mechanisms implicated in the development of cancer.
-end-


Far Eastern Federal University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.